Steatosis assessment by controlled attenuation parameter in patients with compensated advanced chronic liver disease.

作者信息

Grgurevic Ivica, Salkic Nermin, Madir Anita, Aralica Gorana

机构信息

Department of Gastroenterology, Hepatology and Clinical Nutrition, University Hospital Dubrava, University of Zagreb School of Medicine and Faculty of Pharmacy and Biochemistry, Zagreb, Croatia.

Department of Gastroenterology and Hepatology, University Hospital Centre Tuzla, Tuzla, Bosnia and Herzegovina.

出版信息

Liver Int. 2020 Jul;40(7):1784-1785. doi: 10.1111/liv.14426. Epub 2020 Mar 17.

DOI:10.1111/liv.14426

PMID:32145702

Abstract

摘要

相似文献

Steatosis assessment by controlled attenuation parameter in patients with compensated advanced chronic liver disease.

Liver Int. 2020 Jul;40(7):1784-1785. doi: 10.1111/liv.14426. Epub 2020 Mar 17.

The clinical value of controlled attenuation parameter for the noninvasive assessment of liver steatosis.

Liver Int. 2016 Dec;36(12):1860-1866. doi: 10.1111/liv.13207. Epub 2016 Aug 6.

Getting closer to a point-of-care diagnostic assessment in patients with chronic liver disease: controlled attenuation parameter for steatosis.

J Hepatol. 2014 May;60(5):910-2. doi: 10.1016/j.jhep.2014.01.017. Epub 2014 Jan 31.

How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.

Liver Int. 2014 Jul;34(6):e111-7. doi: 10.1111/liv.12305. Epub 2013 Sep 4.

Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: a meta-analysis of diagnostic accuracy.

J Gastroenterol Hepatol. 2014 Jun;29(6):1149-58. doi: 10.1111/jgh.12519.

[Controlled attenuation parameter is a novel technique in screening for non-alcoholic fatty liver disease].

Ugeskr Laeger. 2018 Jan 29;180(5).

The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan.

Clin Res Hepatol Gastroenterol. 2012 Feb;36(1):13-20. doi: 10.1016/j.clinre.2011.08.001. Epub 2011 Sep 15.

Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.

J Gastroenterol Hepatol. 2014;29(7):1470-6. doi: 10.1111/jgh.12557.

Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.

J Hepatol. 2014 May;60(5):1026-31. doi: 10.1016/j.jhep.2013.12.018. Epub 2013 Dec 28.

Diagnostic accuracy of controlled attenuation parameter measured by transient elastography for the non-invasive assessment of liver steatosis: a prospective study.

J Gastrointestin Liver Dis. 2015 Mar;24(1):35-42. doi: 10.15403/jgld.2014.1121.mlp.

引用本文的文献

Ultrasound Methods for the Assessment of Liver Steatosis: A Critical Appraisal.

Diagnostics (Basel). 2022 Sep 22;12(10):2287. doi: 10.3390/diagnostics12102287.

Use of biochemical parameters for non-invasive screening of oesophageal varices in comparison to elastography-based approach in patients with compensated advanced chronic liver disease.

Biochem Med (Zagreb). 2022 Jun 15;32(2):020712. doi: 10.11613/BM.2022.020712.

Ultrasound Elastography-Cornerstone of Non-Invasive Metabolic Dysfunction-Associated Fatty Liver Disease Assessment.

Medicina (Kaunas). 2021 May 21;57(6):516. doi: 10.3390/medicina57060516.

Liver and Nonliver-Related Outcomes at 2 Years Are Not Influenced by the Results of the FIB-4 Test and Liver Elastography in a Real-Life Cohort of Patients with Type 2 Diabetes.

Can J Gastroenterol Hepatol. 2021 Mar 8;2021:5582813. doi: 10.1155/2021/5582813. eCollection 2021.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验